1. Home
  2. AUUD vs LIXT Comparison

AUUD vs LIXT Comparison

Compare AUUD & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUUD
  • LIXT
  • Stock Information
  • Founded
  • AUUD 2012
  • LIXT 2005
  • Country
  • AUUD United States
  • LIXT United States
  • Employees
  • AUUD N/A
  • LIXT N/A
  • Industry
  • AUUD Computer Software: Prepackaged Software
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AUUD Technology
  • LIXT Health Care
  • Exchange
  • AUUD Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • AUUD 2.9M
  • LIXT 3.0M
  • IPO Year
  • AUUD 2021
  • LIXT N/A
  • Fundamental
  • Price
  • AUUD $6.12
  • LIXT $0.74
  • Analyst Decision
  • AUUD
  • LIXT
  • Analyst Count
  • AUUD 0
  • LIXT 0
  • Target Price
  • AUUD N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • AUUD 66.5K
  • LIXT 82.2K
  • Earning Date
  • AUUD 08-06-2025
  • LIXT 08-07-2025
  • Dividend Yield
  • AUUD N/A
  • LIXT N/A
  • EPS Growth
  • AUUD N/A
  • LIXT N/A
  • EPS
  • AUUD N/A
  • LIXT N/A
  • Revenue
  • AUUD N/A
  • LIXT N/A
  • Revenue This Year
  • AUUD N/A
  • LIXT N/A
  • Revenue Next Year
  • AUUD N/A
  • LIXT N/A
  • P/E Ratio
  • AUUD N/A
  • LIXT N/A
  • Revenue Growth
  • AUUD N/A
  • LIXT N/A
  • 52 Week Low
  • AUUD $2.88
  • LIXT $0.64
  • 52 Week High
  • AUUD $31.62
  • LIXT $3.00
  • Technical
  • Relative Strength Index (RSI)
  • AUUD 49.64
  • LIXT 30.79
  • Support Level
  • AUUD $4.11
  • LIXT $0.64
  • Resistance Level
  • AUUD $4.54
  • LIXT $0.93
  • Average True Range (ATR)
  • AUUD 0.41
  • LIXT 0.13
  • MACD
  • AUUD -0.08
  • LIXT -0.05
  • Stochastic Oscillator
  • AUUD 30.77
  • LIXT 16.99

About AUUD Auddia Inc.

Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: